Fate Therapeutics, Inc. (FRA:F6T)
0.8170
-0.0218 (-2.60%)
At close: Dec 30, 2025
Revenue by Product
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.